Human KLF16 recombinant protein decreased serum CK-MB and CK levels, inhibited myocardial damage, diminished LVEDD, LVESD and LVSD levels, and increased LVEF level in mice with myocardial ischemia-reperfusion (Figure 2(a-g)). Here, KLF16 is linked to myocardial ischemia.